91 related articles for article (PubMed ID: 27891589)
1. Critical roles of conventional dendritic cells in promoting T cell-dependent hepatitis through regulating natural killer T cells.
Wang J; Cao X; Zhao J; Zhao H; Wei J; Li Q; Qi X; Yang Z; Wang L; Zhang H; Bai L; Wu Z; Zhao L; Hong Z; Yin Z
Clin Exp Immunol; 2017 Apr; 188(1):127-137. PubMed ID: 27891589
[TBL] [Abstract][Full Text] [Related]
2. Activation of Liver X Receptor α Sensitizes Mice to T-Cell Mediated Hepatitis.
Gao L; Li B; Wang J; Shen D; Yang M; Sun R; Tung HC; Xu M; Ren S; Zhang M; Yang D; Lu B; Wang H; Liu Y; Xie W
Hepatol Commun; 2020 Nov; 4(11):1664-1679. PubMed ID: 33163836
[TBL] [Abstract][Full Text] [Related]
3. Dendritic Cells as Sensors, Mediators, and Regulators of Ischemic Injury.
Dai H; Thomson AW; Rogers NM
Front Immunol; 2019; 10():2418. PubMed ID: 31681306
[TBL] [Abstract][Full Text] [Related]
4. [Novel strategy of sepsis immunomodulation targeting dendritic cells].
Yao YM; Zhang H; Wu Y
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi; 2023 Jul; 39(7):606-611. PubMed ID: 37805688
[TBL] [Abstract][Full Text] [Related]
5. Pathogenesis of liver injury in acute liver failure.
Chung RT; Stravitz RT; Fontana RJ; Schiodt FV; Mehal WZ; Reddy KR; Lee WM
Gastroenterology; 2012 Sep; 143(3):e1-e7. PubMed ID: 22796239
[No Abstract] [Full Text] [Related]
6. A four-cell pathway orchestrated by Flt3-L-dependent cDCs controls anti-tumor responses.
Aliazis K; Boussiotis VA
Cell Rep Med; 2024 Jan; 5(1):101378. PubMed ID: 38232704
[TBL] [Abstract][Full Text] [Related]
7. Dendritic cells take on more tasks in the liver?
Duffield JS
Hepatology; 2012 Jan; 55(1):16-9. PubMed ID: 22120933
[No Abstract] [Full Text] [Related]
8. Polymeric Particle BAM15 Targeting Macrophages Attenuates the Severity of LPS-Induced Sepsis: A Proof of Concept for Specific Immune Cell-Targeted Therapy.
Udompornpitak K; Bhunyakarnjanarat T; Saisorn W; Manipuntee C; Plengplang K; Sittichaitaweekul S; Jenphatanapong P; Udomkarnjananun S; Kaewduangduen W; Ariya-Anandech K; Samaeng A; Insin N; Ritprajak P; Leelahavanichkul A
Pharmaceutics; 2023 Nov; 15(12):. PubMed ID: 38140036
[TBL] [Abstract][Full Text] [Related]
9. Purinergic receptor P2Y12 boosts autoimmune hepatitis through hexokinase 2-dependent glycolysis in T cells.
Zhuang W; Liu X; Liu G; Lv J; Qin H; Wang C; Xie L; Saimaier K; Han S; Shi C; Hua Q; Zhang R; Du C
Int J Biol Sci; 2023; 19(11):3576-3594. PubMed ID: 37497007
[TBL] [Abstract][Full Text] [Related]
10. Activation of cDCs and iNKT cells contributes to triptolide-induced hepatotoxicity via STING signaling pathway and endoplasmic reticulum stress.
Chen X; Yu Z; Nong C; Xue R; Zhang M; Zhang Y; Sun L; Zhang L; Wang X
Cell Biol Toxicol; 2023 Aug; 39(4):1753-1772. PubMed ID: 36520315
[TBL] [Abstract][Full Text] [Related]
11. Patients with treated autoimmune hepatitis and persistent suppression of plasmacytoid dendritic cells: A different point of view.
Dos Santos IP; de Assunção MT; Mauch RM; Sandy NS; Nolasco da Silva MT; Bellomo-Brandão MA; Riccetto AGL
Int J Immunopathol Pharmacol; 2022; 36():20587384211068667. PubMed ID: 35404689
[No Abstract] [Full Text] [Related]
12. Concanavalin A-induced autoimmune hepatitis model in mice: Mechanisms and future outlook.
Liu Y; Hao H; Hou T
Open Life Sci; 2022; 17(1):91-101. PubMed ID: 35291566
[TBL] [Abstract][Full Text] [Related]
13. Preclinical models of acute liver failure: a comprehensive review.
Hefler J; Marfil-Garza BA; Pawlick RL; Freed DH; Karvellas CJ; Bigam DL; Shapiro AMJ
PeerJ; 2021; 9():e12579. PubMed ID: 34966588
[TBL] [Abstract][Full Text] [Related]
14. Small molecules in targeted cancer therapy: advances, challenges, and future perspectives.
Zhong L; Li Y; Xiong L; Wang W; Wu M; Yuan T; Yang W; Tian C; Miao Z; Wang T; Yang S
Signal Transduct Target Ther; 2021 May; 6(1):201. PubMed ID: 34054126
[TBL] [Abstract][Full Text] [Related]
15. MAdCAM-1/α4β7 Integrin-Mediated Lymphocyte/Endothelium Interactions Exacerbate Acute Immune-Mediated Hepatitis in Mice.
Schippers A; Hübel J; Heymann F; Clahsen T; Eswaran S; Schlepütz S; Püllen R; Gaßler N; Tenbrock K; Tacke F; Wagner N
Cell Mol Gastroenterol Hepatol; 2021; 11(4):1227-1250.e1. PubMed ID: 33316453
[TBL] [Abstract][Full Text] [Related]
16. Critical roles of conventional dendritic cells in autoimmune hepatitis via autophagy regulation.
Fan X; Men R; Huang C; Shen M; Wang T; Ghnewa Y; Ma Y; Ye T; Yang L
Cell Death Dis; 2020 Jan; 11(1):23. PubMed ID: 31932577
[TBL] [Abstract][Full Text] [Related]
17. Improvement of mesenchymal stromal cells and their derivatives for treating acute liver failure.
Hu C; Li L
J Mol Med (Berl); 2019 Aug; 97(8):1065-1084. PubMed ID: 31197403
[TBL] [Abstract][Full Text] [Related]
18. The Role of Myeloid-Derived Cells in the Progression of Liver Disease.
Weston CJ; Zimmermann HW; Adams DH
Front Immunol; 2019; 10():893. PubMed ID: 31068952
[TBL] [Abstract][Full Text] [Related]
19. Mesenchymal Stem Cells as New Therapeutic Agents for the Treatment of Primary Biliary Cholangitis.
Arsenijevic A; Harrell CR; Fellabaum C; Volarevic V
Anal Cell Pathol (Amst); 2017; 2017():7492836. PubMed ID: 29410945
[TBL] [Abstract][Full Text] [Related]
20. Myeloid Cells and Chronic Liver Disease: a Comprehensive Review.
Lian M; Selmi C; Gershwin ME; Ma X
Clin Rev Allergy Immunol; 2018 Apr; 54(2):307-317. PubMed ID: 29313221
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
